<DOC>
	<DOC>NCT02056717</DOC>
	<brief_summary>The primary purpose of this study is to investigate the effects of dexamethasone on inflammatory reactions after uterine artery embolization. The secondary purpose of this study it to investigate the effects of dexamethasone on postembolization syndrome (severe pain, nasea and vomiting).</brief_summary>
	<brief_title>Use of Dexamethasone in Uterine Artery Embolization</brief_title>
	<detailed_description />
	<mesh_term>Adenomyosis</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Uterine artery embolization due to multiple myoma or adenomyosis Diabetic mellitus Steroid administration Liver or kidney dysfuntion High baseline CRP or leukocytosis (&gt;11,000/Î¼L ) Drug allergy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>